The U.S. Centers for Disease Control and Prevention is warning Americans about a possible shortage in obtaining Adderall, a key treatment for attention-deficit hyperactivity disorder or ADHD.

ADHD Advisor examined data from the Drug Enforcement Administration and other sources to see why the Adderall shortage continues and why it matters.

Tangent The CDC’s warning comes after the FDA said the ADHD medication supply had improved in May. Adderall was the first drug to be listed as being in a shortage in October 2022.

The CDC released a statement warning of an increased risk of drug injuries and overdoses after the U.S. Department of Justice indicted two executives from the telehealth company Done on Thursday.

Months after the Food and Drug Administration first indicated that there was a shortage of ADHD drugs, suppliers are warning that those shortfalls could continue throughout the year -- a source of ...

The disruption also coincides with an ongoing prescription drug shortage that includes ADHD drugs, the CDC said. Ruthia He, the founder and CEO of Done Global Inc., was arrested in Los Angeles ...

The CDC cautioned that the disruption from lost access to Done Global prescriptions comes amid a long-standing, nationwide shortage of Adderall and other stimulant medications.

The CDC issued an official health advisory warning about a "potential disrupted access to care among individuals taking prescription stimulant medications and possible increased risks for injury ...